Curcumin prevents corticosterone-induced neurotoxicity and abnormalities of neuroplasticity via 5-HT receptor pathway

J Neurochem. 2011 Sep;118(5):784-95. doi: 10.1111/j.1471-4159.2011.07356.x. Epub 2011 Jul 18.

Abstract

Curcumin, a major active component of Curcuma longa, possesses antioxidant and neuroprotective activities. The present study explores the mechanisms underlying the neuroprotective effect of curcumin against corticosterone and its relation to 5-hydroxy tryptamine (5-HT) receptors. Exposure of cortical neurons to corticosterone results in decreased mRNA levels for three 5-HT receptor subtypes, 5-HT(1A), 5-HT(2A) and 5-HT(4), but 5-HT(1B,) 5-HT(2B), 5-HT(2C), 5-HT(6) and 5-HT(7) receptors remain unchanged. Pre-treatment with curcumin reversed this effect on mRNA for the 5-HT(1A) and 5-HT(4) receptors, but not for the 5-HT(2A) receptor. Moreover, curcumin exerted a neuroprotective effect against corticosterone-induced neuronal death. This observed effect of curcumin was partially blocked by either 5-HT(1A) receptor antagonist p-MPPI or 5-HT(4) receptor antagonist RS 39604 alone; whereas, the simultaneous application of both antagonists completely reversed the effect. Curcumin was also found to regulate corticosterone-induced morphological changes such as increases in soma size, dendritic branching and dendritic spine density, as well as elevate synaptophysin expression in cortical neurons. p-MPPI and RS 39604 reversed the effect of curcumin-induced change in neuronal morphology and synaptophysin expression of corticosterone-treated neurons. In addition, an increase in cyclic adenosine monophosphate (cAMP) level was observed after curcumin treatment, which was further prevented by RS 39604, but not by p-MPPI. However, curcumin-induced elevation in protein kinase A activity and phosphorylation of cAMP response element-binding protein levels were inhibited by both p-MPPI and RS 39604. These findings suggest that the neuroprotection and modulation of neuroplasticity exhibited by curcumin might be mediated, at least in part, via the 5-HT receptor-cAMP-PKA-CREB signal pathway.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Analysis of Variance
  • Animals
  • Animals, Newborn
  • Anti-Inflammatory Agents / toxicity*
  • CREB-Binding Protein / metabolism
  • Cell Survival / drug effects
  • Cells, Cultured
  • Cerebral Cortex / cytology
  • Corticosterone / toxicity*
  • Curcumin / pharmacology*
  • Cyclic AMP / metabolism
  • Cyclic AMP-Dependent Protein Kinases / metabolism
  • Dose-Response Relationship, Drug
  • Fluoxetine / pharmacology
  • Gene Expression Regulation / drug effects
  • Neuronal Plasticity / drug effects*
  • Neurons / drug effects*
  • Neuroprotective Agents / pharmacology*
  • RNA, Messenger / metabolism
  • Rats
  • Rats, Sprague-Dawley
  • Receptors, Serotonin, 5-HT1 / genetics
  • Receptors, Serotonin, 5-HT1 / metabolism*
  • Selective Serotonin Reuptake Inhibitors / pharmacology
  • Signal Transduction / drug effects*
  • Transfection / methods

Substances

  • Anti-Inflammatory Agents
  • Neuroprotective Agents
  • RNA, Messenger
  • Receptors, Serotonin, 5-HT1
  • Serotonin Uptake Inhibitors
  • Fluoxetine
  • Cyclic AMP
  • CREB-Binding Protein
  • Cyclic AMP-Dependent Protein Kinases
  • Curcumin
  • Corticosterone